Chemed’s VITAS Healthcare Faces Scrutiny Over Hospice Overbilling

Chemed: Hospice Subsidiary VITAS Healthcare Overutilizing Intensive Services at Medicare’s Expense; Company Has Long History of Improper Billing Practices

As the Trump Administration continues its crackdown on hospice fraud, a Capitol Forum investigation has found that VITAS Healthcare, a subsidiary of Chemed (CHE) and the largest hospice operator in the country, may be systematically overbilling Medicare by tens of millions of dollars annually. Moreover, this practice has drawn repeated scrutiny from government watchdogs over […]

KKR and Kuvare: KKR and Kuvare Life Insurers File Conflicting Sworn Accounts of the Same Reinsurance Deal, $542 Million Apart on the Money Set Aside for Policyholders

Kuvare Holdings-owned Guaranty Income Life Insurance Company and KKR-owned (KKR) Commonwealth Annuity and Life Insurance Company are telling their respective state regulators materially different...

Sep 02, 2026 Read Now >

Health Care Weekly: Florida AG Accuses PBMs of Price-Fixing; Acquisitions of Pending Pharma IP Should Face Antitrust Scrutiny, FTC Says; FDA Targets Online Peptide Sellers; Medicare DME Moratorium Ends; Dialysis Giants Comment on ESRD Proposal; Update on FDA Warnings About Clinical Trial Disclosures

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week...

Sep 02, 2026 Read Now >

Tech/Media/Telecom Weekly: A Look at Potential Midterm Outcomes; Canada Could Target Energy and Critical Materials in Trade War; White House Looks to Shield Bulk-Power Equipment from Outside Interference; California Strips Private Right of Action from Privacy Act

The TMT Weekly is a forward-looking tipsheet that covers tech policy across The Capitol Forum’s U.S. policy coverage universe, from Congress to the courts. If you have any feedback, feel free to...

Sep 01, 2026 Read Now >

Chemed: Hospice Subsidiary VITAS Healthcare Overutilizing Intensive Services at Medicare’s Expense; Company Has Long History of Improper Billing Practices

RELATED ARTICLES | Corporate investigations

KKR and Kuvare: KKR and Kuvare Life Insurers File Conflicting Sworn Accounts of the Same Reinsurance Deal, $542 Million Apart on the Money Set Aside for Policyholders

Health Care Weekly: Florida AG Accuses PBMs of Price-Fixing; Acquisitions of Pending Pharma IP Should Face Antitrust Scrutiny, FTC Says; FDA Targets Online Peptide Sellers; Medicare DME Moratorium Ends; Dialysis Giants Comment on ESRD Proposal; Update on FDA Warnings About Clinical Trial Disclosures

Tech/Media/Telecom Weekly: A Look at Potential Midterm Outcomes; Canada Could Target Energy and Critical Materials in Trade War; White House Looks to Shield Bulk-Power Equipment from Outside Interference; California Strips Private Right of Action from Privacy Act

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.